146 related articles for article (PubMed ID: 38428707)
1. White Paper: American Gastroenterological Association Position Statement: The Future of IBD Care in the United States-Removing Barriers and Embracing Opportunities.
Sofia MA; Feuerstein JD; Narramore L; Chachu KA; Streett S
Clin Gastroenterol Hepatol; 2024 May; 22(5):944-955. PubMed ID: 38428707
[TBL] [Abstract][Full Text] [Related]
2. Advocating for Patients With Inflammatory Bowel Disease: How to Navigate the Prior Authorization Process.
Bhat S; Zahorian T; Robert R; Farraye FA
Inflamm Bowel Dis; 2019 Sep; 25(10):1621-1628. PubMed ID: 30753551
[TBL] [Abstract][Full Text] [Related]
3. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults.
Lamb CA; Kennedy NA; Raine T; Hendy PA; Smith PJ; Limdi JK; Hayee B; Lomer MCE; Parkes GC; Selinger C; Barrett KJ; Davies RJ; Bennett C; Gittens S; Dunlop MG; Faiz O; Fraser A; Garrick V; Johnston PD; Parkes M; Sanderson J; Terry H; ; Gaya DR; Iqbal TH; Taylor SA; Smith M; Brookes M; Hansen R; Hawthorne AB
Gut; 2019 Dec; 68(Suppl 3):s1-s106. PubMed ID: 31562236
[TBL] [Abstract][Full Text] [Related]
4. AGA Clinical Practice Update on Diet and Nutritional Therapies in Patients With Inflammatory Bowel Disease: Expert Review.
Hashash JG; Elkins J; Lewis JD; Binion DG
Gastroenterology; 2024 Mar; 166(3):521-532. PubMed ID: 38276922
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Inflammatory Bowel Disease in Canada 2018: Direct Costs and Health Services Utilization.
Kuenzig ME; Benchimol EI; Lee L; Targownik LE; Singh H; Kaplan GG; Bernstein CN; Bitton A; Nguyen GC; Lee K; Cooke-Lauder J; Murthy SK
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S17-S33. PubMed ID: 31294382
[TBL] [Abstract][Full Text] [Related]
6. Approaches to improve quality of care in inflammatory bowel diseases.
Shah R; Hou JK
World J Gastroenterol; 2014 Jul; 20(28):9281-5. PubMed ID: 25071321
[TBL] [Abstract][Full Text] [Related]
7. Delay in prior authorization of biologic therapy: Another possible cause of healthcare disparity in IBD patients.
Rao V; Dharia I; Gibilisco J; Kirelik D; Baumgartner S; Negreira K; Chawla K; Dave J; Kallus S; Belfaqeeh OA; Borum ML
J Natl Med Assoc; 2024 Feb; 116(1):13-15. PubMed ID: 38036315
[TBL] [Abstract][Full Text] [Related]
8. American Gastroenterological Association medical position statement: parenteral nutrition.
American Gastroenterological Association
Gastroenterology; 2001 Oct; 121(4):966-9. PubMed ID: 11606511
[TBL] [Abstract][Full Text] [Related]
9. Economic Burden and Health Care Access for Patients With Inflammatory Bowel Diseases in China: Web-Based Survey Study.
Yu Q; Zhu C; Feng S; Xu L; Hu S; Chen H; Chen H; Yao S; Wang X; Chen Y
J Med Internet Res; 2021 Jan; 23(1):e20629. PubMed ID: 33399540
[TBL] [Abstract][Full Text] [Related]
10. Current Landscape of Telemedicine Practice in Inflammatory Bowel Disease.
Patil SA; Cross RK
Inflamm Bowel Dis; 2018 Aug; 24(9):1910-1917. PubMed ID: 29718218
[TBL] [Abstract][Full Text] [Related]
11. Access to inflammatory bowel disease speciality care: the primary healthcare physician perspective.
Burns EE; Mathias HM; Heisler C; Cui Y; Kits O; Veldhuyzen van Zanten S; Jones JL
Fam Pract; 2021 Jul; 38(4):416-424. PubMed ID: 33615344
[TBL] [Abstract][Full Text] [Related]
12. Translating improved quality of care into an improved quality of life for patients with inflammatory bowel disease.
Siegel CA; Allen JI; Melmed GY
Clin Gastroenterol Hepatol; 2013 Aug; 11(8):908-12. PubMed ID: 23747710
[TBL] [Abstract][Full Text] [Related]
13. IBD Around the world: comparing the epidemiology, diagnosis, and treatment: proceedings of the World Digestive Health Day 2010--Inflammatory Bowel Disease Task Force meeting.
Baumgart DC; Bernstein CN; Abbas Z; Colombel JF; Day AS; D'Haens G; Dotan I; Goh KL; Hibi T; Kozarek RA; Quigley EM; Reinisch W; Sands BE; Sollano JD; Steinhart AH; Steinwurz F; Vatn MH; Yamamoto-Furusho JK
Inflamm Bowel Dis; 2011 Feb; 17(2):639-44. PubMed ID: 20725944
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Inflammatory Bowel Disease in Canada 2018: Children and Adolescents with IBD.
Carroll MW; Kuenzig ME; Mack DR; Otley AR; Griffiths AM; Kaplan GG; Bernstein CN; Bitton A; Murthy SK; Nguyen GC; Lee K; Cooke-Lauder J; Benchimol EI
J Can Assoc Gastroenterol; 2019 Feb; 2(Suppl 1):S49-S67. PubMed ID: 31294385
[TBL] [Abstract][Full Text] [Related]
15. The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
Rubin DT; Feld LD; Goeppinger SR; Margolese J; Rosh J; Rubin M; Kim S; Rodriquez DM; Wingate L
Inflamm Bowel Dis; 2017 Feb; 23(2):224-232. PubMed ID: 27997434
[TBL] [Abstract][Full Text] [Related]
16. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive Use of the Pediatric IBD Collaborative Research Forum.
Markowitz J; Grancher K; Mandel F; Daum F
Am J Gastroenterol; 1993 Jan; 88(1):44-8. PubMed ID: 8420272
[TBL] [Abstract][Full Text] [Related]
18. Burden of comorbid anxiety and depression in patients with inflammatory bowel disease: a systematic literature review.
Dubinsky MC; Dotan I; Rubin DT; Bernauer M; Patel D; Cheung R; Modesto I; Latymer M; Keefer L
Expert Rev Gastroenterol Hepatol; 2021 Sep; 15(9):985-997. PubMed ID: 34130572
[TBL] [Abstract][Full Text] [Related]
19. Optimising the Inflammatory Bowel Disease Unit to Improve Quality of Care: Expert Recommendations.
Louis E; Dotan I; Ghosh S; Mlynarsky L; Reenaers C; Schreiber S
J Crohns Colitis; 2015 Aug; 9(8):685-91. PubMed ID: 25987349
[TBL] [Abstract][Full Text] [Related]
20. Systematic review: the quality of the scientific evidence and conflicts of interest in international inflammatory bowel disease practice guidelines.
Feuerstein JD; Akbari M; Gifford AE; Cullen G; Leffler DA; Sheth SG; Cheifetz AS
Aliment Pharmacol Ther; 2013 May; 37(10):937-46. PubMed ID: 23550536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
